1. Stocks
    2. /
  2. Clinuvel Pharmaceuticals (ASX: CUV)
    3. /

Clinuvel Pharmaceuticals (ASX: CUV) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Clinuvel Pharmaceuticals Chart and Price Data

Fundamentals Data provided by Morningstar.

Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

    • Clinuvel Pharmaceuticals (ASX: CUV)
    Latest News

    Smiling man with phone in wheelchair watching stocks and trends on computer
    Share Market News

    5 things to watch on the ASX 200 on Tuesday

    | James Mickleboro

    A better session is expected for Aussie investors today.

    Read more »

    Shot of a young scientist using a digital tablet while working in a lab.
    Healthcare Shares

    Which ASX biotech shares are pioneering the future of medicine?

    | Kate O'Brien

    Uncover the risks and rewards of high-stakes investments in ASX biotech stocks.

    Read more »

    A young female investor sits in her home office looking at her ipad and smiling as she sees the QBE share price rising
    Broker Notes

    7 ASX All Ords shares elevated to 'strong buy' status in March

    | Bronwyn Allen

    There are blue chips and small caps on this list.

    Read more »

    Kid on a skateboard with cardboard wings soars along the road.
    How to invest

    Shares vs. property: Why cheaper homes and ASX small-cap shares are rising fastest in 2024

    | Bronwyn Allen

    We look into the changing trends in shares vs. property.

    Read more »

    A beautiful woman holds up one finger with one hand and has her hand on her waist with the other as she smiles widely as though she is very pleased about something.
    Share Gainers

    Why Beach, Clinuvel, Deep Yellow, and EML shares are charging higher today

    | James Mickleboro

    These ASX shares are ending the week strongly. But why?

    Read more »

    A man clenches his fists in excitement as gold coins fall from the sky.
    Share Gainers

    Why Arafura, Bubs, Clinuvel, and Superloop shares are racing higher today

    | James Mickleboro

    Why are investors getting excited about these shares today?

    Read more »

    Man with rocket wings which have flames coming out of them.
    Broker Notes

    These ASX shares could rise 30% to 50% in 12 months

    | James Mickleboro

    Big returns could be on the cards for owners of these shares according to analysts.

    Read more »

    A young male investor wearing a white business shirt screams in frustration with his hands grasping his hair after ASX 200 shares fell rapidly today and appear to be heading into a stock market crash
    Share Fallers

    Why Clinuvel, Medibank, Sayona Mining, and Tabcorp shares are sinking today

    | James Mickleboro

    These ASX shares are out of favour with investors on Thursday. But why?

    Read more »

    A cute young girl wearing gumboots and play clothes holds open the door of her wooden cubby house as she sits and smiles in a backyard outdoor setting.
    How to invest

    Is buying investment property in regional areas like buying ASX small-cap shares?

    | Bronwyn Allen

    Will population changes and economic growth in the regions lead to more people buying investment properties there? And is this…

    Read more »

    A man holding a cup of coffee puts his thumb up and smiles while at laptop.
    Small Cap Shares

    Morgans names 7 small-cap ASX shares to buy for earnings season

    | James Mickleboro

    Here are a number of small caps that the broker has given the thumbs up to this week.

    Read more »

    A smiling woman holds a Facebook like sign above her head.
    Growth Shares

    Big returns could be coming for these ASX growth shares in 2024

    | James Mickleboro

    Analysts think these growth stocks could be good portfolio additions this year.

    Read more »

    A smiling businessman in the city looks at his phone and punches the air in celebration of good news.
    Growth Shares

    Looking for ASX growth shares to buy? These could rise ~30%

    | James Mickleboro

    Analysts are tipping big returns for shareholders of these growing companies.

    Read more »

    Frequently Asked Questions

    Yes, Clinuvel Pharmaceuticals has historically paid one unfranked shareholder dividend a year.

    Clinuvel Pharmaceuticals generally pays its shareholder dividend in September.

    Clinuvel Pharmaceuticals does not have a dividend reinvestment plan.

    Clinuvel Pharmaceuticals Limited listed on the ASX on 13 February 2001.

    CUV ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Clinuvel Pharmaceuticals

    Clinuvel Pharmaceuticals Ltd (ASX: CUV) is an Australian-based global biopharmaceutical company developing drugs for the treatment of genetic and vascular disorders. Its principal product SCENESSE is a drug for an inherited disorder, erythropoietic protoporphyria, that causes an intolerance to light.

    Its pioneering work aims at preventing the symptoms of skin diseases related to exposure to UV radiation and at repigmentation of the skin due to depigmentation disorders. Geographically, the company derives the majority of its revenue from its US and European markets.

     

    Profile

    since

    Note